%0 Journal Article
%T Advantages and disadvantages of the use of the CSF Amyloid ¦Â (A¦Â) 42/40 ratio in the diagnosis of Alzheimer¡¯s Disease
%A Henrik Zetterberg
%A Markus Otto
%A Oskar Hansson
%A Sylvain Lehmann
%J Archive of "Alzheimer's Research & Therapy".
%D 2019
%R 10.1186/s13195-019-0485-0
%X CSF biomarkers to distinguish cases with ADD from cases with non-AD
%K Alzheimer¡¯s Disease
%K Amyloid¦Â Peptides
%K A¦Â42/40 ratio
%K Biomarkers
%K Cerebrospinal Fluid
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6477717/